MedTech Strategist Subscriber Home Page

Article content is available to paid MedTech Strategist subscribers only; subscribers log in here. Join our subscriber community today by calling 888-202-5939, e-mail info@medtechstrategist.com, or contact us via our new website – thank you for your interest!

Eighty-three (83) MedTech Strategist issues (605+ ARTICLES TO DATE) have published since its launch in September 2014. Content below includes all articles published to date; articles may be listed under more than one category. Special Editions of the publication are also included.

IMPORTANT UPDATE: We are upgrading our subscriber content and full archives to a brand new, user-friendly web platform – stay tuned for details!

This content is restricted to subscribers

IMPORTANT UPDATE: We are upgrading our subscriber content and full archives to a brand new, user-friendly web platform – stay tuned for details!

Articles by Topic

Obesity - “Will Allurion’s Gastric Balloon Platform Grow the Obesity Market?” by Mary Stuart

Start-Ups To Watch: "Verisante Technology: Enabling Real-Time, Multispectral Noninvasive Cancer Diagnosis," by Wendy Diller

Technology Trends: “Myoscience: The Promise of Cold Therapy,” by David Cassak

Start-Ups To Watch—“Thync: A Noninvasive Bioelectronic Medicine Treats Psoriasis by Targeting Inflammation,” by Mary Stuart

Start-Ups to Watch – “DermTech: The First Noninvasive Gene Expression Test for Skin Cancer,” by Mary Stuart

Under the Lens: “Action Potential: A Drug Giant Bets on Neuromodulation,” by David Cassak

Market Update: “Diabetes Devices: Engineering the Future,” by Mary Thompson

Under the Lens - Glaucoma: "AcuMEMS: Continuous Monitoring For Glaucoma Patients Preserves Vision," by Mary Stuart

Industry Spotlight - Diabetes: "The Bioartificial Pancreas: Edging Toward Reality," by Mary Thompson

“Hello Pharma? Diabetes is Calling; How Eli Lilly is Leveraging Digital Diabetes Device Technologies to Help Grow its Future,” by Mary Thompson

Emerging Markets: "Navigating China's Medical Device Minefield," by Mary Thompson

Industry Spotlight: "Orthopedics M&A: Rebalancing Portfolios in a Transforming Healthcare Market," by Tracy Neilssien

Inside Story: "Medtronic and Covidien's $43B Marriage: An Interview with Medtronic's Geoff Martha," by David Cassak

Market Trends: "BD/CareFusion: Medtech Consolidation Continues," by David Cassak and Wendy Diller

Money Matters: "FIRE1: A New Model for Early-Stage Device Incubation," by David Cassak

Venture Capital - “Innogest and the Virtues of Focused Investing,” by David Cassak

Start-Ups to Watch: "BioParadox: Cell Therapy for Cardiovascular Disease at the Point of Care," by Mary Stuart

Industry Spotlight: "Direct Flow Medical: Leading TAVI's Next Wave," by Stephen Levin

Medtech Investing: “Beyond Ardian: Lightstone’s Contrarian Bet that Big Investment in Early-Stage Devices Can Pay,” by Wendy Diller

Deal Structures: “Innovative Deal Structures: Planning For Exits,” by Stephen Levin

Start-Ups to Watch—"Magnolia Medical: A Simple Solution With a Big Impact on Blood Draw Contamination,” by Wendy Diller

Precision Medicine - “OpGen’s Bet on Precision Antibiotics,” by Wendy Diller

Start-Ups to Watch - "Consano Medical: 'Intelligent' Urinary Catheter Enables Early Sepsis Detection," by Stephen Levin

Start-Ups to Watch: “Stasys Medical: Life-Saving Point-of-Care Test for Trauma-Induced Coagulopathy,” by Mary Stuart

MedTech Strategist Special MedTech Innovator Issue, January 8, 2019

Market Update: “Diabetes Devices: Engineering the Future,” by Mary Thompson

Industry Spotlight - Diabetes: "The Bioartificial Pancreas: Edging Toward Reality," by Mary Thompson

“Hello Pharma? Diabetes is Calling; How Eli Lilly is Leveraging Digital Diabetes Device Technologies to Help Grow its Future,” by Mary Thompson

Start-Ups to Watch: “InSpark Technologies: Predictive Patterns Guide Diabetes Management,” by Mary Stuart

Start-Ups to Watch: “NovioSense: Tracking Glucose in Tears,” by Mary Thompson

Start-Ups to Watch—"Magnolia Medical: A Simple Solution With a Big Impact on Blood Draw Contamination,” by Wendy Diller

Precision Medicine - “OpGen’s Bet on Precision Antibiotics,” by Wendy Diller

Start-Ups to Watch: "Transplant Genomics: Improving Organ Transplant Management with Gene-Based Tests," by Wendy Diller

Technology Trends: “Nueon: Taking the Cuffs off Hypertension Diagnosis,” by Stephen Levin

Start-Ups to Watch: “Stasys Medical: Life-Saving Point-of-Care Test for Trauma-Induced Coagulopathy,” by Mary Stuart

Start-Ups to Watch—"NightWare: Putting Nightmare Disorder to Rest,” by Colin Miller

Precision Medicine - “OpGen’s Bet on Precision Antibiotics,” by Wendy Diller

Obesity - “Will Allurion’s Gastric Balloon Platform Grow the Obesity Market?” by Mary Stuart

Start-Ups to Watch: "Compellon: Turning Big Data into Actionable Data," by Mary Stuart

Start-Ups to Watch - "Consano Medical: 'Intelligent' Urinary Catheter Enables Early Sepsis Detection," by Stephen Levin

Emerging Markets: "Navigating China's Medical Device Minefield," by Mary Thompson

Inside Story: “Where is Medtech Innovation Headed? – A Discussion with Medtronic’s Steve Oesterle, MD,” by David Cassak

Industry Outlook: “Looking Forward to 2015 in the Medtech Industry,” by The MedTech Strategist Editorial Team

Perspective—“China and the Value of Speed to Scale,” by David Cassak

Executive Interviews - “Finding Success in China: The Biosensors Story,” by David Cassak

Inside Story: "Medtronic and Covidien's $43B Marriage: An Interview with Medtronic's Geoff Martha," by David Cassak

Inside Story: "MegaMergers and the Evolving Medical Device Industry: Part II of our Interview with Medtronic's Geoff Martha," by David Cassak

Deal Structures: “Innovative Deal Structures: Planning For Exits,” by Stephen Levin

“The Challenge of Pediatric Device Development,” by Bridget Shaia & Andrew Millar, Health Advances

“Hello Pharma? Diabetes is Calling; How Eli Lilly is Leveraging Digital Diabetes Device Technologies to Help Grow its Future,” by Mary Thompson

Obesity - “Will Allurion’s Gastric Balloon Platform Grow the Obesity Market?” by Mary Stuart

Market Update: “Next-Gen Synthetic Sealants and Glues: Shifting the Surgical Paradigm,” by Mary Thompson

Technology Trends: “Colon Cancer: Technology Advances Seek to Close Screening & Prevention Gap,” by Mary Thompson

Start-Ups to Watch: “Allurion Technologies: A Treatment For Obesity That’s Easy To Swallow,” by Mary Stuart

Start-Ups to Watch—"Omniscient: Increasing Adenoma Detection Rates during Screening Colonoscopy,” by Mary Stuart

Start-Ups to Watch - "EndoSphere Surgical: Enabling Laparoscopy and NOTES with Better Visualization," by Mary Stuart

MedTech Strategist Special MedTech Innovator Issue, January 8, 2019

Start-Ups To Watch: "4Dx: Improving Lung Disease Detection," by Tracy Neilssien

Technology Trends: “Colon Cancer: Technology Advances Seek to Close Screening & Prevention Gap,” by Mary Thompson

Start-Ups to Watch—"Omniscient: Increasing Adenoma Detection Rates during Screening Colonoscopy,” by Mary Stuart

Venture Capital - “Innogest and the Virtues of Focused Investing,” by David Cassak

Under the Lens: "Amid the Biotech Boom, a Fragile Device IPO Window Opens," by Wendy Diller

Money Matters: "Deal Labs: Bringing a New Kind of Crowdfunding to Medtech," by Stephen Levin

Market Trends: "BD/CareFusion: Medtech Consolidation Continues," by David Cassak and Wendy Diller

Money Matters: "FIRE1: A New Model for Early-Stage Device Incubation," by David Cassak

Start-Ups to Watch—"NightWare: Putting Nightmare Disorder to Rest,” by Colin Miller

Medtech Investing: “Beyond Ardian: Lightstone’s Contrarian Bet that Big Investment in Early-Stage Devices Can Pay,” by Wendy Diller

Deal Structures: “Innovative Deal Structures: Planning For Exits,” by Stephen Levin

Under the Lens: “Action Potential: A Drug Giant Bets on Neuromodulation,” by David Cassak

“Mayo Clinic’s Eko Partnership Typifies its Approach to AI Innovation,” by Mark Ratner

Start-Ups to Watch: "Fibralign: Regenerative Medicine Approach to Secondary Lymphedema," by Tracy Neilssien

“Mayo Clinic’s Eko Partnership Typifies its Approach to AI Innovation,” by Mark Ratner

MedTech Strategist Special MedTech Innovator Issue, January 8, 2019

Start-Ups To Watch: "Verisante Technology: Enabling Real-Time, Multispectral Noninvasive Cancer Diagnosis," by Wendy Diller

Start-Ups To Watch: "4Dx: Improving Lung Disease Detection," by Tracy Neilssien

Medtech Investing: "VCs Favor Ophthalmology, Orthopedics Devices," by Wendy Diller

Under the Lens - Glaucoma: "AcuMEMS: Continuous Monitoring For Glaucoma Patients Preserves Vision," by Mary Stuart

Start-Ups to Watch: “NovioSense: Tracking Glucose in Tears,” by Mary Thompson